✦ LIBER ✦

MAINTENANCE MEDICATION FOR CHRONIC SCHIZOPHRENICS: RISK/BENEFIT ASSESSMENT

✍ Scribed by PAMELA L. DRISCOLL

Book ID: 114833796
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 613 KB
Volume: 23
Category: Article
ISSN: 0031-5990
DOI: 10.1111/j.1744-6163.1985.tb00264.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Silver Products for Medical Indications:

Silver Products for Medical Indications: Risk-Benefit Assessment

✍ Fung, Man C.; Bowen, Debra L. 📂 Article 📅 1996 🏛 Informa plc 🌐 English ⚖ 677 KB

A Tiered Approach for Risk-Benefit Asses

A Tiered Approach for Risk-Benefit Assessment of Foods

✍ Heidi Fransen; Nynke De Jong; Marieke Hendriksen; Marcel Mengelers; Jacqueline C 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

Medication maintenance of chronic schizo

Medication maintenance of chronic schizophrenic out–patients by a psychiatric clinical pharmacist: 10–year follow–up study

✍ A. Dorevitch; R. Aronzon; L. Zilberman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Minimal maintenance medication: Effects

Minimal maintenance medication: Effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients

✍ Heinz E. Lehmann; William H. Wilson; Mina Deutsch 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 841 KB

Medical treatment for primary sclerosing

Medical treatment for primary sclerosing cholangitis: Risk versus benefit

✍ Paul Angulo; Keith D. Lindor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Background: No established medical therapy alters the progressive course of primary sclerosing cholangitis. Objective: To explore the potential usefulness of combined therapy with azathioprine, steroids and ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis. Design: Case series. Setting:

Antiarrhythmic drugs for the maintenance

Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefits

✍ John Camm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 414 KB